Metropolitan Life Insurance Company (MetLife)’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,918
| Closed | -$7K | – | 2410 |
|
|
2023
Q2 | $7K | Buy |
+1,918
| New | +$7K | ﹤0.01% | 2428 |
|
|
2022
Q1 | – | Sell |
-8,675
| Closed | -$98.1K | – | 2348 |
|
|
2021
Q4 | $98.1K | Sell |
8,675
-401
| -4% | -$4.54K | ﹤0.01% | 2496 |
|
|
2021
Q3 | $132K | Buy |
9,076
+301
| +3% | +$4.39K | ﹤0.01% | 2364 |
|
|
2021
Q2 | $102K | Buy |
8,775
+1,129
| +15% | +$13.2K | ﹤0.01% | 2583 |
|
|
2021
Q1 | $93.3K | Sell |
7,646
-1,209
| -14% | -$14.8K | ﹤0.01% | 2447 |
|
|
2020
Q4 | $111K | Hold |
8,855
| – | – | ﹤0.01% | 2308 |
|
|
2020
Q3 | $133K | Hold |
8,855
| – | – | ﹤0.01% | 2049 |
|
|
2020
Q2 | $217K | Buy |
8,855
+1,700
| +24% | +$41.7K | ﹤0.01% | 1739 |
|
|
2020
Q1 | $102K | Hold |
7,155
| – | – | ﹤0.01% | 2019 |
|
|
2019
Q4 | $114K | Buy |
+7,155
| New | +$114K | ﹤0.01% | 2255 |
|